Stockholders' Equity and Warrants

3 Months Ended

Mar. 31, 2013

Stockholders' Equity and Warrants

11. Stockholders’ Equity and Warrants

Authorized Common Stock

At March 31, 2013, the Company had 240,000,000 shares of common stock authorized.

Financings

On February 25, 2009, the Company sold 14,378,698 shares of its common stock in a registered direct offering to institutional investors, at a purchase price of $1.69 per share, resulting in net proceeds after fees and expenses of $22.8 million. The investors also received warrants to purchase an additional 10,784,024 shares of the Company’s common stock exercisable at a price of $2.15 per share in cash or pursuant to the net exercise provisions of the warrants. The warrants became exercisable on August 25, 2009 and expired on February 25, 2012. Through December 31, 2011, a total of 4,978,181 warrants were exercised by the holders for proceeds to the Company of approximately $10.7 million. In the first quarter of 2012, the remaining 5,805,843 warrants were exercised by the holders for proceeds to the Company of approximately $12.5 million. Prior to exercise, the warrants were recorded at fair value, with the adjustment to carrying value recognized in earnings. Upon exercise, the sum of the fair value of the exercised warrants and the proceeds received were credited to additional paid-in-capital and totaled $87.0 million in the first quarter of 2012. Upon the exercise of these remaining warrants in February 2012, the balance of the warrant liability was credited to stockholders’ equity and the liability was eliminated.

On December 14, 2011, the Company filed a shelf registration statement with the Securities and Exchange Commission (“SEC”), for the issuance of an unspecified amount of common stock, preferred stock, various series of debt securities and/or warrants to purchase any of such securities, either individually or in units, from time to time at prices and on terms to be determined at the time of any such offering. This registration statement was effective upon filing and will remain in effect for up to three years from filing.

On January 29, 2013, the Company sold 16,489,893 shares of its common stock in an underwritten public offering at a purchase price of $19.60 per share. Net proceeds of this offering, after underwriting discounts and commissions and expenses, were approximately $310.0 million.

Changes in Stockholders’ Equity

The changes in stockholders’ equity for the three-month period ended March 31, 2013 were as follows:

	Common Stock				Additional Paid-in Capital			Accumulated Other Comprehensive Income			Accumulated Deficit			Total
$ in thousands	Shares		Amount
Balance, January 1, 2013		167,075,758	$	167	$	890,499		$	20		$	(777,835	)	$	112,851
Issuance of common stock pursuant to ARIAD stock plans		986,523		1		1,521									1,522
Issuance of common stock, net of issuance costs		16,489,893		17		310,020									310,037
Stock-based compensation						5,610									5,610
Payment of tax withholding obligations related to stock-based compensation						(1,392	)								(1,392	)
Net unrealized losses on marketable securities									(5	)					(5	)
Cumulative translation adjustment									23						23
Net loss												(64,670	)		(64,670	)
Balance, March 31, 2013		184,552,174	$	185	$	1,206,258		$	38		$	(842,505	)	$	363,976